UCLA Department of Medicine Division of Clinical Immunology, David Geffen School of Medicine — Los Angeles, California

UCLA Department of Medicine Division of Clinical Immunology, David Geffen School of Medicine is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

UCLA Department of Medicine Division of Clinical Immunology, David Geffen School of Medicine has participated in 1 clinical trials.

Therapeutic areas: Hereditary Angioedema.

Sponsors: Pharming Technologies B.V..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Department of Medicine Division of Clinical Immunology, David Geffen School of Medicine?

UCLA Department of Medicine Division of Clinical Immunology, David Geffen School of Medicine has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Department of Medicine Division of Clinical Immunology, David Geffen School of Medicine conducted?

UCLA Department of Medicine Division of Clinical Immunology, David Geffen School of Medicine has 1 clinical trials on record. Their work covers Hereditary Angioedema.

Is UCLA Department of Medicine Division of Clinical Immunology, David Geffen School of Medicine accredited by Crixeo Health?

UCLA Department of Medicine Division of Clinical Immunology, David Geffen School of Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Department of Medicine Division of Clinical Immunology, David Geffen School of Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.